Cargando…
Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614528/ https://www.ncbi.nlm.nih.gov/pubmed/35833300 http://dx.doi.org/10.3324/haematol.2022.281004 |
| _version_ | 1784820215562895360 |
|---|---|
| author | Stephens, Deborah M. Li, Hongli Constine, Louis S. Fitzgerald, Thomas J. Leonard, John P. Kahl, Brad S. Song, Joo Y. LeBlanc, Michael L. Smith, Sonali M. Persky, Daniel O. Friedberg, Jonathan W. |
| author_facet | Stephens, Deborah M. Li, Hongli Constine, Louis S. Fitzgerald, Thomas J. Leonard, John P. Kahl, Brad S. Song, Joo Y. LeBlanc, Michael L. Smith, Sonali M. Persky, Daniel O. Friedberg, Jonathan W. |
| author_sort | Stephens, Deborah M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9614528 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96145282022-11-03 Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 Stephens, Deborah M. Li, Hongli Constine, Louis S. Fitzgerald, Thomas J. Leonard, John P. Kahl, Brad S. Song, Joo Y. LeBlanc, Michael L. Smith, Sonali M. Persky, Daniel O. Friedberg, Jonathan W. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-07-14 /pmc/articles/PMC9614528/ /pubmed/35833300 http://dx.doi.org/10.3324/haematol.2022.281004 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Stephens, Deborah M. Li, Hongli Constine, Louis S. Fitzgerald, Thomas J. Leonard, John P. Kahl, Brad S. Song, Joo Y. LeBlanc, Michael L. Smith, Sonali M. Persky, Daniel O. Friedberg, Jonathan W. Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 |
| title | Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 |
| title_full | Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 |
| title_fullStr | Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 |
| title_full_unstemmed | Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 |
| title_short | Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 |
| title_sort | extranodal presentation in limited-stage diffuse large b-cell lymphoma as a prognostic marker in three swog trials s0014, s0313 and s1001 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614528/ https://www.ncbi.nlm.nih.gov/pubmed/35833300 http://dx.doi.org/10.3324/haematol.2022.281004 |
| work_keys_str_mv | AT stephensdeborahm extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT lihongli extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT constinelouiss extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT fitzgeraldthomasj extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT leonardjohnp extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT kahlbrads extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT songjooy extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT leblancmichaell extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT smithsonalim extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT perskydanielo extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 AT friedbergjonathanw extranodalpresentationinlimitedstagediffuselargebcelllymphomaasaprognosticmarkerinthreeswogtrialss0014s0313ands1001 |